Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →A data-backed look at single cell combinatorial split-pool barcoding patents: who leads the 76-record field, where filing activity has moved, and which claim classes are most contested going into 2026.
Filing growth = 2021 (6 records) → 2024 (5); 2024 is the last year we treat as complete.
This landscape covers 76 published patent families matching single-cell split-pool combinatorial barcoding methods, filed between 2015 and the 2026 data cut-off. The search isolates records that combine single-cell analysis with split-pool combinatorial chemistry and explicit barcoding steps, distinguishing this technical route from droplet- or well-based single-cell isolation methods that sit outside this scope.
Filing activity peaked in 2018 and has since eased on the most recent complete year-over-year comparison available, while claims remain heavily concentrated in enzymatic and DNA measurement methods rather than spread evenly across the supporting bioinformatics, separation and synthesis steps.
Pick a task. Every answer cites the patents behind it.
The 76 records in scope span 2015 to the 2026 cut-off, with filing activity concentrated in a handful of enzymatic and combinatorial-chemistry subclasses rather than spread evenly across the field.
Filings ran from 6 in 2012 up to a peak of 16 in 2018. Using 2021 (6 filings) to 2024 (5 filings) — the most recent span with complete publication data — filings moved -17% over three years. 2025 and 2026 figures will still rise as later filings publish, so they should not be read as a continued decline yet.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
C12Q (measuring and testing involving enzymes and DNA) appears in 78.9% of the 76 records, far ahead of C12N genetic engineering (35.5%) and G01N material analysis (23.7%). Bioinformatics (G16B) and combinatorial libraries (C40B) trail at 13.2% and 10.5%, and since records can carry multiple IPC classes these shares add up to more than 100%.
Shares are the percentage of the 76 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about single cell combinatorial split-pool barcoding method patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaProvided herein, among other things, is a method for spatial single cell analysis. In some embodiments, the method may comprise: obtaining a cellular sample comprising nucleic acid molecules, binding spatial tags to the sample, removing any unbound or unreacted spatial tags, determining the location and identity of the spatial tag, dissociating the sample into single cells, performing single cell sequencing, determine the spatial barcode for each single cell, and assigning the single cell sequencing reads to its spatial location.Filed by Scale Biosciences Inc., published 2024-10-10 as WO2024211058A1.


When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three figures from this dataset matter most for anyone deciding where to file, license or design around existing claims in split-pool barcoding.
The top-ranked assignee holds 22 of the 76 tracked patent families against a fifth-place count of 7 and a tenth-place count of 4. That drop-off means the core method claims in this space sit disproportionately with one company, not spread across the 36 ranked filers.
Filings peaked at 16 in 2018 and have since eased; the most recent complete comparison shows a -17% move over three years. Publication lag means 2025 and 2026 counts will still rise as later filings publish, so this is not evidence of an accelerating decline.
C12Q, covering enzymatic and DNA measurement methods, appears in 78.9% of the 76 records in scope — far ahead of C12N genetic engineering at 35.5% and G01N material analysis at 23.7%. New filers should expect the densest prior art here.
Among receiving offices, the United States leads with 30 filings, ahead of the WIPO PCT route at 18 and the European Patent Office at 16. Smaller jurisdictions such as Austria, Germany and Australia account for a handful of filings each.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to single cell combinatorial split-pool barcoding method patent landscape, with the prior art for and against each one.
The figures above establish the shape of the field. The next step is usually specific to what you're deciding — where to file, who to watch, or what to design around.
With one filer holding 22 of the 76 tracked families, any new filing in split-pool barcoding should be checked against that portfolio's claim scope first, particularly in the dense C12Q enzymatic-methods territory.
Search the leader's full portfolio in EurekaCurrent 2025 and 2026 counts understate real filing activity because of publication lag. Revisit the trend once another year of data has published to see whether the -17% three-year move continues or reverses.
Set a filing alert in EurekaB01D and C12P each sit under 4% of records, well below the C12Q core. That gap is worth a closer look for anyone drafting claims around the physical or biochemical steps that support split-pool workflows.
Explore white space in EurekaThe assignee ranking for this dataset covers 36 companies, and the leader holds 22 of the tracked patent families, well ahead of the fifth-ranked filer at 7 and the tenth-ranked filer at 4. That gap means claim density in the core enzymatic tagging methods is concentrated in one filer's portfolio rather than distributed across the field. The remainder of the ranking includes a long tail of research institutions and diagnostics companies with single-digit filing counts, so licensing or freedom-to-operate checks should prioritise the leader first and then work down the ranked list.
This dataset is scoped specifically to split-pool combinatorial barcoding, which tags cells or nuclei through sequential rounds of pooling and splitting rather than isolating each cell in a droplet or well. That distinction matters for prior art searches because droplet-based methods sit largely outside this corpus and carry a separate body of claims. Practitioners should treat the IPC composition here — heavily weighted toward C12Q enzymatic methods and C40B combinatorial libraries — as characteristic of the split-pool approach specifically, not of single-cell barcoding generally.
Filing activity peaked at 16 in 2018 and, using the most recent complete comparison available (2021 at 6 filings versus 2024 at 5 filings), moved -17% over that three-year span. That is a measured decline, not a collapse, and it should not be read as the field slowing further based on 2025 or 2026 counts, since publication typically lags filing by around 18 months and those years are still filling in. A clearer read on the current trajectory will only be possible once another one to two years of filings have published.
C12Q (enzymatic and DNA measurement methods) is the class to check first, appearing in 78.9% of the 76 records in scope, followed by C12N genetic engineering constructs at 35.5% and G01N material analysis methods at 23.7%. Bioinformatics claims under G16B and combinatorial library claims under C40B are smaller but still material at 13.2% and 10.5% respectively. Because a single patent record can carry several IPC classes, a thorough search needs to clear all of these rather than treating them as separate, non-overlapping search buckets.
Among the receiving offices captured in this dataset, the United States leads with 30 filings, followed by the WIPO PCT route at 18 and the European Patent Office at 16, with smaller counts in Austria, Germany and Australia. That pattern points to the US and the PCT system as the primary venues for establishing priority in this space, with Europe as a secondary but still active jurisdiction. Anyone clearing a specific national market should still confirm coverage locally, since PCT filings can later enter national phase in jurisdictions not separately broken out here.
Go past this page: query the whole single cell combinatorial split-pool barcoding method patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page